TRANEXAMIC ACID IN SODIUM CHLORIDE
NDC 51754-0108, tranexamic acid, injection, solution, from Exela Pharma Sciences, LLC.
- Product NDC
- 51754-0108
- Status
- Listed
- Labeler
- Exela Pharma Sciences, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212020
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51754-0108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID10 mg/mL
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51754-0108-1 | 51754010801 | 100 mL in 1 BAG (51754-0108-1) |
| 51754-0108-3 | 51754010803 | 1000 mL in 1 CASE (51754-0108-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/db36ddf2-4ac5-47ac-bdce-e3fa6983073e
Use it
Look up 51754-0108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51754-0108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51754-0108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.